Surgery and inhibitor development in hemophilia A: a systematic review. - Wikidata - wikimedia - TriplyDB

Surgery and inhibitor development in hemophilia A: a systematic review.

Surgery and inhibitor development in hemophilia A: a systematic review.

http://www.wikidata.org/entity/Q37916686

about

Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery Treatment for preventing bleeding in people with congenital bleeding disorders undergoing surgery Different impact of factor VIII products on inhibitor development?Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.Alloantibodies in previously untreated hemophilia A patients: the role of environmental factors.Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control study.Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A.New findings on inhibitor development: from registries to clinical studies.Retrospective analysis of in vivo recovery and clearance during continuous infusion of recombinant factor VIII products: a single-institution study.Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.Neonatal circumcision in severe haemophilia: a survey of paediatric haematologists at United States Hemophilia Treatment Centers.The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A.Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients.Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre.Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: non-interventional, observational study in patients with severe haemophilia A.Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A.Continuous infusion of coagulation factor concentrates during intensive treatment.Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.Guidelines for the management of hemophilia.Dissecting intensive treatment as risk factor for inhibitor development in haemophilia.

P2860

Q24188177-56E501A2-017E-4E09-98C6-39C55008C044 Q24202459-9A581851-0B9D-4F33-B1E5-6039193EE6EE Q28075679-D143AA2C-8F05-4DEC-A043-0C05EA8BE3BC Q37212741-D7C369DA-5E6E-4390-9315-46F467C9B81E Q38080144-E6EC564A-D697-4036-88B7-2C16436D0EF2 Q38691244-873EE458-3DC7-418C-847D-81C481B0EAD5 Q38828174-9DBB4FE5-5B77-4885-A510-85400486E11D Q39042987-C0248C6C-9CC3-449D-A4B5-AEE103E916A7 Q40553769-0DD6F792-9303-4278-AB56-33FD62F15C2E Q41592459-B882C861-A6FE-4BFE-8A5E-447B342B137D Q41729620-BC6FB5DE-AE0C-4099-BA41-CC65742850E9 Q42211106-C168503B-339A-4FAC-92DB-BC91AAFB7B61 Q45838031-14E44E83-00A0-44FF-B5C4-D5A0C190F6A8 Q45855455-738D2F58-D8F4-480B-B053-A81CD061F055 Q45857838-314C446F-DA54-421D-95A3-E7771E4DA413 Q45870824-DD5D842E-CFD2-42A3-985B-69658FF5A377 Q45871101-A31CBE3A-3EE5-405D-B9EB-E613BF27964F Q45871553-331B9D12-EEEA-4380-89B3-58B3AB2BDCEC Q45875860-EB33F8B3-2B28-4779-A1CC-7F6F4B21D0C3 Q45880345-4912C0F9-A785-440B-9E83-CA5B62655FD5 Q45885031-1398120E-5A2B-48A0-BDCD-0B252262764C

P2860

Surgery and inhibitor development in hemophilia A: a systematic review.

http://www.wikidata.org/entity/Q37916686

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Surgery and inhibitor development in hemophilia A: a systematic review.

@en

Surgery and inhibitor development in hemophilia A: a systematic review.

@nl

type

label

Surgery and inhibitor development in hemophilia A: a systematic review.

@en

Surgery and inhibitor development in hemophilia A: a systematic review.

@nl

prefLabel

Surgery and inhibitor development in hemophilia A: a systematic review.

@en

Surgery and inhibitor development in hemophilia A: a systematic review.

@nl

P1433

Q37916686-A3C8C5B3-1DC2-409A-8D69-5EFB6B15AF71

P1476

Q37916686-154B6633-3B31-41A6-9238-9F1A8A409382

P2093

Q37916686-3BE7CB04-4EEA-4E35-9490-FF8593E30149

Q37916686-4E163C9D-1F0B-4045-92EB-B48DB111A28D

Q37916686-59326749-2EB9-4F00-ADFD-84180013B18C

Q37916686-71D471D2-AD7C-4BD4-8E0E-2539570ED098

Q37916686-BB3AE028-B0FE-4616-BBDF-69E8DF6D1708

Q37916686-CB4E59C4-9952-414E-90BF-6AF58E5B9A1E

P2860

Q37916686-036FEA1D-2D40-408D-86E6-D0C87629B9A5

Q37916686-047D4127-EAC8-4190-96A9-6415212A5AF9

Q37916686-16DD7EC1-FD75-496F-AEA4-0942442C59F5

Q37916686-19664027-E222-4980-A492-FCF246FB8EBB

Q37916686-2012CFC9-9C72-4548-85DD-43E7F8C5811D

Q37916686-2D01C15F-1835-47C1-AE9A-5C5D1007C19B

Q37916686-3036DF47-77DC-41DE-9765-670831BE94B2

Q37916686-3DEEC11C-34BE-41E9-AF50-594210C607CC

Q37916686-424EBE67-3269-4B85-817B-879B24935FB0

Q37916686-445E65A9-C2A1-4E56-A132-59B834F970D4

P304

Q37916686-C1F872C6-3EF4-4D8D-91FF-F8519342C201

P31

Q37916686-F6DAEBA5-1EFC-4E36-89DA-B3D0140CE8CB

P356

Q37916686-E843D857-0833-4ABC-8678-7A08E250EFA1

P433

Q37916686-DEFB17AA-9335-415F-8123-A9368D87FE1D

P478

Q37916686-60969343-0ECB-4893-A33A-F546F074297A

P577

Q37916686-E887554A-9403-4B7D-A80F-52EBC87DB762

P5875

Q37916686-A7D5CCB5-B539-4970-957E-88F503FE8323

P698

Q37916686-B62BBA7B-42AB-4474-AA68-CEE09890DA5D

P921

Q37916686-2F286537-9DE4-4472-A36C-BFD34C41420F

Q37916686-D99E2A01-2707-4E69-9845-75DF62591A62

P356

J.1538-7836.2011.04467.X

P1433

Journal of Thrombosis and Haemostasis

P1476

Surgery and inhibitor development in hemophilia A: a systematic review.

@en

P2093

C L Eckhardt

http://www.w3.org/2001/XMLSchema#string

J G van der Bom

http://www.w3.org/2001/XMLSchema#string

K Fijnvandraat

http://www.w3.org/2001/XMLSchema#string

M Peters

http://www.w3.org/2001/XMLSchema#string

M van der Naald

http://www.w3.org/2001/XMLSchema#string

P W Kamphuisen

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

The danger model: a renewed sense of self

Factor VIII inhibitors. Potential for prevention of inhibitor formation by immune tolerance.

Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years.

Mild hemophilia A.

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

The epidemiology of inhibitors in haemophilia A: a systematic review.

Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

Immune response against therapeutic factor VIII in hemophilia A patients--a survey of probable risk factors.

Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development.

P304

1948-1958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2011.04467.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51568678

http://www.w3.org/2001/XMLSchema#string

P698

21838755

http://www.w3.org/2001/XMLSchema#string

P921